A 12-year-old girl presented with a 15 × 15 cm, rapidly enlarging mass in left breast. Fine-needle aspiration cytology showed a benign proliferative breast lesion. Total excision of the mass was done preserving nipple and areola. Histopathology features were suggestive of giant fibroadenoma with benign phyllodes.
trauma, nipple discharge, fever, anorexia, or weight loss. There was no significant family history. On examination, enlargement of the left breast was seen; the right breast was normal. It was a 15 × 15 cm, solitary, well-circumscribed, firm mass, which was nontender and not adherent to the underlying structures. There was no axillary lymphadenopathy. She was in Tanner Stage 2 of sexual maturity. Systemic examination was normal. Fibroadenoma of breast was suspected but due to the rapid rate of enlargement and large size, malignant phyllodes could not be ruled out. Blood counts were within normal limits. Fine needle aspiration from the mass was suggestive of benign proliferative breast lesion. Total excision of the mass preserving the nipple and areola was done. The cut surface of the lump was tan colored, lobulated with slit-like spaces, with intervening grey white fibrous tissue in between the nodules and focal hemorrhages, (Fig. 1) . Histopathology showed proliferation of stromal connective tissue which surrounded the ductules in a circumferential pattern (pericanalicular type), stroma containing dense fibrous and collagenous tissue admixed with loose fibroblastic tissue, (Fig. 2) . A leaf-like pattern of stroma was also noted. All the features were suggestive of fibroadenoma with benign phyllodes. The girl is being regularly followed up for the last year and is doing well. Any variation in its normal progression often deserves attention. Virginal hypertrophy, giant fibroadenoma, and cystosarcoma phyllodes are the important differential diagnoses to be considered when one encounters a large breast mass. Although the majority of breast disorders in pediatric patients are benign, the presence of any breast mass frequently raises parental concerns of a potential cancer. 1, 2 Juvenile or giant fibroadenoma is a rare pathology usually presenting in adolescence characterized by massive and rapid enlargement of the breast. Distinguishing it from cystosarcoma phyllodes preoperatively is difficult, but is important as they have a different therapeutic approach and different follow-up. 1 We report a case of giant fibroadenoma of the breast in a 12-year-old girl and discuss the diagnostic possibilities with a review of literature.
Case Report
A 12-year-old girl presented with history of rapidly enlarging left breast of two weeks duration. The mass was painless, and gradually increased to attain the size of 15 × 15 cm, with no history of 
Discussion
Breast masses can arise during any stage of puberty, so it is important to understand normal breast development. Thelarche usually begins between the ages of 9 and 10 years. Sexual maturity rating (SMR) or Tanner stages are used to describe breast development.
The prepubertal stage is SMR 1; the development of budlike breast growth underneath the areola is SMR 2. In SMR 3, there is a greater volume of breast tissue, and the areola is larger but lays flat against the contour of the breast tissue. Larger breast size and a larger raised areola, which forms a second mound on top of the breast tissue, characterize SMR 4. The final stage is typically SMR 5, in which breasts attain adult size, and the areola returns to the contour of the breast tissue. 3 Fibroadenomas are the most commonly (68%) encountered breast mass in adolescents and are believed to be caused by an abnormal response to estrogen. They typically present as rubbery, discrete, nontender mass, and may be lobular, bilateral (10%), or multiple (10% to 15%). 4 The most common location is the outer upper quadrant of the breast. 5 In adolescent and young adult patients, fibroadenomas are usually not associated with malignancies. The giant fibroadenoma (juvenile cellular fibroadenoma) is an uncommon variant (4%) of fibroadenoma characterized by rapid growth. Peak incidence occurs in late adolescence, with African-American females at increased risk. The size of the lesion is usually more than 5 cm but is encapsulated and benign. The underlying mass may cause a major distortion to the breast contour. 6 Dupont describes two histological groups of fibroadenomas, simple and complex. Complex fibroadenoma refers to fibroadenomas with foci of cysts, sclerosing adenosis, epithelial calcifications, and papillary apocrine metaplasia, and has a higher future risk of malignancy. 7 The diagnosis of large breast tumors in adolescent females rests primarily on three possibilities: giant fibroadenoma, cystosarcoma phyllodes, and virginal hypertrophy. It is important to distinguish these three pathological entities preoperatively as they have different therapeutic approach. Most of the times, physical examination, imaging like ultrasonography of breasts, mammography, and magnetic resonance imaging fail to make diagnosis. 8 Histologically, giant fibroadenomas have to be differentiated from cystosarcoma phyllodes by the lack of leaf-like structures and stromal cell atypia and from asymmetric breast hypertrophy in girls by the lack of mammary lobules. 9 Other infrequent causes include post-traumatic fat necrosis and mastitis. In fat necrosis of breast, usually a distinct lump need not be palpable while in mastitis all features of inflammation are seen. 10 Fortunately, majority of these tumors can be completely excised, preserving the nipple and areola, as was done in our patient. Giant juvenile fibroadenoma may recur after complete excision, but the chance of recurrence becomes less after third decade. 11 Although malignant tumors of the breast are rare in the adolescent age group, 2% of all primary malignant breast lesions occur under the age of 25 years in females.
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Conclusion
Understanding various breast pathologies, a complete physical examination, and diagnostic evaluation are needed to reassure the patient and the parents as well as to avoid missing any rare malignant lesion.
